Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells.
about
The Role of Forkhead Box Protein M1 in Breast Cancer Progression and Resistance to TherapyRoles for miRNAs in endocrine resistance in breast cancerPrognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System ReviewGSAASeqSP: a toolset for gene set association analysis of RNA-Seq dataKinetochore genes are coordinately up-regulated in human tumors as part of a FoxM1-related cell division program.Glyceollins trigger anti-proliferative effects through estradiol-dependent and independent pathways in breast cancer cellsFoxM1 influences embryo implantation and is regulated by 17 beta-estradiol and progesterone in mouse uteri and endometrium cells.A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.Suppression of the FOXM1 transcriptional programme via novel small molecule inhibitionOPN induces FoxM1 expression and localization through ERK 1/2, AKT, and p38 signaling pathway in HEC-1A cells.Resistance to HER2-targeted therapies: a potential role for FOXM1.The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cellsIdentification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia.Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer.Unravelling the genomic targets of small molecules using high-throughput sequencing.Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.A FOXM1 Dependent Mesenchymal-Epithelial Transition in Retinal Pigment Epithelium Cells.The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients.Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cellsIdentification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technologyNF-Y Binding Site Architecture Defines a C-Fos Targeted Promoter ClassDifferential network analysis reveals the genome-wide landscape of estrogen receptor modulation in hormonal cancersModeling co-occupancy of transcription factors using chromatin featuresAnalysis of aggregated cell-cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells.Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer.DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells.Dissecting the genomic activity of a transcriptional regulator by the integrative analysis of omics data.InFlo: a novel systems biology framework identifies cAMP-CREB1 axis as a key modulator of platinum resistance in ovarian cancer.FOXM1 binds directly to non-consensus sequences in the human genome.FoxM1 influences mouse hepatocellular carcinoma metastasis in vitroHigh level PHGDH expression in breast is predominantly associated with keratin 5-positive cell lineage independently of malignancy.Deregulation of the FOXM1 target gene network and its coregulatory partners in oesophageal adenocarcinoma.LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression.Fox transcription factors: from development to disease.A high-resolution transcriptome map of cell cycle reveals novel connections between periodic genes and cancer.The Overexpression of CARM1 Promotes Human Osteosarcoma Cell Proliferation through the pGSK3β/β-Catenin/cyclinD1 Signaling Pathway.FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypesForkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death.Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.
P2860
Q26768290-03D4B2E1-0F80-489E-97AC-7DD535D4D354Q26783076-55D30389-7028-44EB-B386-29FF96499164Q26785676-0ECFEB2A-55B5-445E-BADE-E1AF76CFD2DEQ30850769-0C5A466F-5390-4911-8EBF-3CB8F5E342B1Q33811933-4A6BA7CF-4772-4AF8-9F3E-B5A358B704FAQ33861798-26D5ADBC-BB69-4936-AF94-22D68AD60C46Q34501562-E9CCBF07-9BBA-449C-95BB-3FD88EB76C4BQ34521706-A5AED476-86DA-4FDF-A243-B007155A3061Q34649774-9BC53E3A-711B-44AA-B880-7CF4653DD635Q34835628-171EF80D-6A0F-442C-A4BC-FCEF7A785B94Q34955355-4D12DD8D-07EE-4B68-98E5-A9BC9D650598Q35000256-4749E166-8679-4F5C-B13A-C59502441D5EQ35197045-59AEB82B-9705-4418-9DD9-5308D948C0FFQ35198542-B90A781E-6530-4A8A-A7ED-8129C130467CQ35328171-AFE0B4AE-3D91-41AA-904C-47BA26298D56Q35524465-1294EB79-BA6C-4E90-8D13-636E7A29D9ACQ35677149-1D9A2211-C3C6-4F5F-BF25-6E2E9C435A6CQ35781316-9B8E68F0-A1F8-43CD-9161-7510BE25D6D0Q35942699-6A45CEE6-A7EB-4DEC-B456-3E1CEE0867CEQ36063718-6A7906C1-9BDE-42FA-8801-50652A63A81CQ36102690-939A61EB-6939-45BE-971B-F029E3AF51E0Q36682166-C0531510-3E40-4562-8213-716E9FDCF7E8Q36701050-304495E1-7495-4208-B446-334186506453Q37005458-97CBAFF0-B9CC-4A26-B487-FC015611E938Q37528915-4E2611D1-7B0A-45FE-8438-EADCAEA61146Q37697488-2199221C-44D6-474E-9B6F-6EC5C33272CAQ37745486-1A06966B-994D-4BD7-8911-73E6372C790EQ38429686-0F42AFD1-11C4-4183-8882-98E6F746DA9AQ38732555-38554B83-2D29-4EAA-9A90-F4DEF1ED7E77Q38861035-D709538E-F1BB-4E00-9CC9-4A1A63219D49Q38867211-44A0EC26-AD03-403C-B055-98F992E31E83Q38869310-59E91EF0-AB6E-4E01-8339-5EB74440D220Q38885266-FD326EBE-7DC1-4800-9BE1-BDE32F28AB6FQ38936732-686A91B2-02BB-461A-B114-21350CDAFC28Q39037983-842CA294-F900-4834-A00B-71BBBED00BBFQ39641111-8CA935C1-645F-433E-9DD6-401BD4957EC2Q41036174-B5733DB7-8B7A-40B4-8C61-0D745E345F68Q41471202-C52F05EC-F19F-476D-AD4F-DB43356229BEQ41698570-0B7F33EC-66B5-45F7-AB31-CFF43A4F840DQ41900139-D66E7030-C104-4C8E-A282-3F797056EEFE
P2860
Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Genome-wide mapping of FOXM1 b ...... alpha in breast cancer cells.
@en
type
label
Genome-wide mapping of FOXM1 b ...... alpha in breast cancer cells.
@en
prefLabel
Genome-wide mapping of FOXM1 b ...... alpha in breast cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Genome-wide mapping of FOXM1 b ...... alpha in breast cancer cells.
@en
P2093
Caryn S Ross-Innes
Deborah A Sanders
Jason S Carroll
Shankar Balasubramanian
P2860
P2888
P356
10.1186/GB-2013-14-1-R6
P577
2013-01-24T00:00:00Z